"Erythrokeratodermia variabilis"

125 resultsPro users have access to +0 Systematic Reviews

Filter Results
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
                    • Pro

                            Clinical Area Pro

                            Further Refinement
                            User Guide

                            User Guide

                            1
                            Protean Cutaneous Manifestation Caused by ABCA12 variants: Erythrokeratodermia Variabilis-like Ichthyosis and Unique Palmoplantar Keratoderma. ABCA12 is crucial for skin barrier function and traditionally linked to severe congenital ichthyosis, such as harlequin ichthyosis. However, its genotype-phenotype relationship may be more nuanced. Using whole-exome sequencing and Sanger sequencing, we identified four cases of mild ichthyosis with biallelic ABCA12 pathogenic variants. In addition to a milder phenotype, the palmoplantar keratoderma (PPK) in these cases had a distinct "mosaic-tile like" pattern. Two cases with missense variants in the N-terminus of ABCA12 also presented an annular ichthyosis pattern resembling erythrokeratodermia variabilis et progressiva (EKVP). Our findings suggest
                            2
                            2022Experimental Dermatology
                            Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4. Erythrokeratodermia variabilis et progressiva (EKVP) is a rare genodermatosis of clinical and genetic heterogeneity, characterized by the manifestations of localized or disseminated persistent hyperkeratotic plagues and stationary to migratory transient erythematous patches. The majority of EKVP cases display
                            Subscribe to Trip PRO for an enhanced experience
                            • Access to millions of Full-text articles where avaliable
                            • Unlock 100,000+ extra articles with Systematic Reviews
                            • Further Filtering Options
                            • No adverts
                            • Advanced Search Ability
                            • Enhanced SmartSearch showing unlimited related articles
                            Read more about Trip PRO
                            3
                            Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia. Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively. In this issue, Boyden et al. (2015) report
                            4
                            2014British Journal of Dermatology
                            The novel GJB3 mutation p.Thr202Asn in the M4 transmembrane domain underlies erythrokeratodermia variabilis.
                            5
                            Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis Et Progressiva, without Features of Oculodentodigital Dysplasia. Genetic investigation of inherited skin disorders has informed the understanding of skin self-renewal, differentiation, and barrier function. Erythrokeratodermia variabilis et progressiva (EKVP) is a rare, inherited skin disease that is characterized
                            6
                            2014eMedicine.com
                            Erythrokeratodermia Variabilis (Diagnosis) Erythrokeratodermia Variabilis et Progressiva: Practice Essentials, Pathophysiology, Epidemiology For YouNews & PerspectiveDrugs & DiseasesCME & EducationAcademyVideoDecision PointEdition:EnglishMedscapeEnglishDeutschEspañolFrançaisPortuguêsUKNewUnivadisLog In Sign Up It's Free!English EditionMedscape * English * Deutsch * Español * Français * Português =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTExMDgyMC1vdmVydmlldw==processing....Drugs & Diseases > Dermatology Erythrokeratodermia Variabilis et ProgressivaUpdated: May 17, 2022 * Author: Gabriele Richard, MD, FACMG; Chief Editor: Dirk M Elston, MD more... * * Share * Email * Print * FeedbackClose * Facebook * Twitter * LinkedIn * WhatsAppSections Erythrokeratodermia Variabilis et Progressiva * * Sections Erythrokeratodermia Variabilis et Progressiva
                            7
                            2014eMedicine.com
                            Erythrokeratodermia Variabilis (Follow-up) Erythrokeratodermia Variabilis et Progressiva Treatment & Management: Medical Care, Long-Term Monitoring For YouNews & PerspectiveDrugs & DiseasesCME & EducationAcademyVideoDecision PointEdition:EnglishMedscapeEnglishDeutschEspañolFrançaisPortuguêsUKNewUnivadisLog In Sign Up It's Free!English EditionMedscape * English * Deutsch * Español * Français =getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTExMDgyMC10cmVhdG1lbnQ=processing....Drugs & Diseases > Dermatology Erythrokeratodermia Variabilis et Progressiva Treatment & ManagementUpdated: May 17, 2022 * Author: Gabriele Richard, MD, FACMG; Chief Editor: Dirk M Elston, MD more... * * Share * Email * Print * FeedbackClose * Facebook * Twitter * LinkedIn * WhatsAppSections
                            8
                            2014eMedicine.com
                            Erythrokeratodermia Variabilis (Overview) Erythrokeratodermia Variabilis et Progressiva: Practice Essentials, Pathophysiology, Epidemiology For YouNews & PerspectiveDrugs & DiseasesCME & EducationAcademyVideoDecision PointEdition:EnglishMedscapeEnglishDeutschEspañolFrançaisPortuguêsUKNewUnivadisLog In Sign Up It's Free!English EditionMedscape * English * Deutsch * Español * Français * Português =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTExMDgyMC1vdmVydmlldw==processing....Drugs & Diseases > Dermatology Erythrokeratodermia Variabilis et ProgressivaUpdated: May 17, 2022 * Author: Gabriele Richard, MD, FACMG; Chief Editor: Dirk M Elston, MD more... * * Share * Email * Print * FeedbackClose * Facebook * Twitter * LinkedIn * WhatsAppSections Erythrokeratodermia Variabilis et Progressiva * * Sections Erythrokeratodermia Variabilis et Progressiva
                            9
                            2014eMedicine.com
                            Erythrokeratodermia Variabilis (Treatment) Erythrokeratodermia Variabilis et Progressiva Treatment & Management: Medical Care, Long-Term Monitoring News & PerspectiveDrugs & DiseasesCME & EducationAcademyVideoDecision PointEdition:EnglishMedscapeEnglishDeutschEspañolFrançaisPortuguêsUKNewUnivadisLog In Sign Up It's Free!English EditionMedscape * English * Deutsch * Español * Français * Português =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTExMDgyMC10cmVhdG1lbnQ=processing....Drugs & Diseases > Dermatology Erythrokeratodermia Variabilis et Progressiva Treatment & ManagementUpdated: May 17, 2022 * Author: Gabriele Richard, MD, FACMG; Chief Editor: Dirk M Elston, MD more... * * Share * Email * Print * FeedbackClose * Facebook * Twitter * LinkedIn * WhatsAppSections Erythrokeratodermia Variabilis et Progressiva * * Sections Erythrokeratodermia
                            10
                            Erythrokeratodermia variabilis: Two case reports Erythrokeratodermia variabilis (EKV) is a rare heterogeneous skin disorder. The classical EKV first described by Mendes da Costa is characterized by two types of skin lesions: (1) figurate hyperkeratotic plaques, and (2) transient erythematous areas. Herein, we report two patients presenting with erythematous and hyperkeratotic lesions that were
                            11
                            2012Acta Dermato-Venereologica
                            Novel Mutation in Gene (Connexin 30.3) in a Family with Erythrokeratodermia Variabilis.
                            12
                            was remarkable. In patients investigated with genetic testing, a heterozygous pathogenic gene variant in the GJB4 (gap junction protein beta-4) gene was found positive for GJB4:c.35G>A (rsrs80358211). One patient also presented a synonymous variant in GJB3:c.357C>T (rs41310442). Variants in GJB4 are classically associated with Erythrokeratodermia variabilis, but there is remarkable clinical heterogeneity. Our
                            13
                            2019British Journal of Dermatology
                            Recessive mosaicism in ABCA12 causes blaschkoid congenital ichthyosiform erythroderma. We report the unique case of a 3-year-old girl who presented with linear erythematosquamous lesions following the lines of Blaschko, suggestive of genetic mosaicism in the skin. Single-candidate gene analyses were performed on DNA from blood, excluding Conradi-Hünermann-Happle syndrome, erythrokeratodermia variabilis and a mosaic presentation of pityriasis rubra pilaris. With whole-exome sequencing (WES) on DNA from the patient's blood, a heterozygous missense mutation in exon 25 of the ABCA12 gene was detected. By manually scrutinizing the WES data, another low-percentage pathogenic frameshift mutation was found in the adjacent exon 26 of the same gene. This frameshift mutation was confirmed with Sanger
                            14
                            , multiple allergies, and metabolic wasting (SAM) syndrome, caused by biallelic desmoglein 1 (DSG1) mutations, exhibit skin lesions reminiscent of erythrokeratodermia variabilis, caused by mutations in connexin (Cx) genes. We, therefore, examined whether SAM syndrome-causing DSG1 mutations interfere with Cx expression and GJ function. Lesional skin biopsies from SAM syndrome patients (n = 7) revealed
                            15
                            2018Experimental Dermatology
                            A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death. Erythrokeratodermia variabilis et progressiva (EKV-P) is caused by mutations in either the GJB3 (Cx31) or GJB4 genes (Cx30.3). We identified a rare GJB3 missense mutation, c.134G>A (p.G45E), in two unrelated patients and investigated its cellular characteristics. Expression
                            16
                            -17-induced targets of A20 show similar aberrant epidermal layer-specific transcriptional upregulation in keratinocytes from diseases as diverse as psoriasis, atopic dermatitis, and erythrokeratodermia variabilis, suggesting a contributory role for epidermal inflammation in a broad spectrum of rashes.
                            17
                            2015JAMA neurology
                            indicated that it was unlikely that these 2 Japanese families shared a common ancestor. Although a missense mutation in ELOVL4 (c.504G>C, p.L168F) was recently reported to be associated with SCA with erythrokeratodermia variabilis (SCA34) in a French-Canadian family, signs of erythrokeratodermia variabilis were absent in our families. Combined with the results of the family with SCA34 reported previously , this report confirms that mutations in ELOVL4 can cause dominantly inherited neurodegeneration severely affecting the cerebellum and brainstem. We should be aware that the presence of multiple system atrophy-like features on magnetic resonance imaging scans, together with cerebellar and brainstem atrophy, suggests SCA34, even when erythrokeratodermia variabilis is absent. The present study further broadened
                            18
                            2014JAMA neurology
                            in a significant proportion of families with SCA remains unexplained. In 1972, a French-Canadian family segregating a combination of SCA and erythrokeratodermia variabilis (EKV) in an autosomal dominant fashion was described. To map and identify the causative gene in this large family with SCA and EKV using a combination of linkage analysis and whole-exome sequencing. A total of 32 individuals from the family
                            19
                            2014eMedicine.com
                            copyrighted by 3rd parties.Close encoded search term (Ainhum (Dactylolysis Spontanea)) and Ainhum (Dactylolysis Spontanea) What to Read Next on Medscape Related Conditions and Diseases * Ainhum * Vohwinkel Syndrome * Amniotic Band Syndrome (Streeter Dysplasia) * Acrokeratoelastoidosis * Erythrokeratodermia Variabilis et Progressiva * Morphea Medscape Consult News & Perspective * Keratosis
                            20
                            2014eMedicine.com
                            * Erythrokeratodermia Variabilis et Progressiva * Subacute Cutaneous Lupus Erythematosus (SCLE) * Hypereosinophilic Syndrome * Oral Manifestations of Systemic Diseases Medscape Consult News & Perspective * Dermatological Complications of Immunosuppressive and Anti-TNF Therapy in Inflammatory Bowel Disease * Cutaneous Signs and Syndromes Associated With Internal Malignancies * Tobacco Use and Skin Disease Tools * Drug Interaction Checker * Pill Identifier * Calculators * FormularyRecommended * 20021081565-overviewDiseases & Conditions Diseases & Conditions Erythema Gyratum Repens * 20021122701-overviewDiseases & Conditions Diseases & Conditions Erythema Annulare Centrifugum * 20021110820-overviewDiseases & Conditions Diseases & Conditions Erythrokeratodermia Variabilis et Progressiva Need